[1]CurrentPatentAssignee:SANFORDBURNHAMPREBYSMEDICALDISCOVERYINSTITUTE-WO2015/200534,2015,A2Locationinpatent:Paragraph00697
[1]Pinkerton,AnthonyB.;Peddibhotla,Satyamaheshwar;Yamamoto,Fusayo;Slosky,LaurenM.;Bai,Yushi;Maloney,Patrick;Hershberger,Paul;Hedrick,MichaelP.;Falter,Bekhi;Ardecky,RobertJ.;Smith,LaytonH.;Chung,ThomasD.Y.;Jackson,MichaelR.;Caron,MarcG.;Barak,LawrenceS.[JournalofMedicinalChemistry,2019,vol.62,#17,p.8357-8363]
[1]Pinkerton,AnthonyB.;Peddibhotla,Satyamaheshwar;Yamamoto,Fusayo;Slosky,LaurenM.;Bai,Yushi;Maloney,Patrick;Hershberger,Paul;Hedrick,MichaelP.;Falter,Bekhi;Ardecky,RobertJ.;Smith,LaytonH.;Chung,ThomasD.Y.;Jackson,MichaelR.;Caron,MarcG.;Barak,LawrenceS.[JournalofMedicinalChemistry,2019,vol.62,#17,p.8357-8363]
[1]Pinkerton,AnthonyB.;Peddibhotla,Satyamaheshwar;Yamamoto,Fusayo;Slosky,LaurenM.;Bai,Yushi;Maloney,Patrick;Hershberger,Paul;Hedrick,MichaelP.;Falter,Bekhi;Ardecky,RobertJ.;Smith,LaytonH.;Chung,ThomasD.Y.;Jackson,MichaelR.;Caron,MarcG.;Barak,LawrenceS.[JournalofMedicinalChemistry,2019,vol.62,#17,p.8357-8363]
Title: Pinkerton AB, et al. Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators. J Med Chem. 2019 Aug 20.
